Sulochana Nursing Home Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 20 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -7.42%
(FY 2021)
- Profit 96.16%
(FY 2021)
- Ebitda 113.93%
(FY 2021)
- Net Worth -6.05%
(FY 2021)
- Total Assets -16.94%
(FY 2021)
About Sulochana Nursing Home
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Waghmare, Arjun Waghmare, Sameer Waghmare, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110MH2005PTC150614
- Company No.
150614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sulochana Nursing Home?
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Waghmare | Director | 13-Jan-2005 | Current |
Pratibha Waghmare | Whole-Time Director | 13-Jan-2005 | Current |
Anil Waghmare | Director | 13-Jan-2005 | Current |
Arjun Waghmare | Director | 13-Jan-2005 | Current |
Sameer Waghmare | Director | 13-Jan-2005 | Current |
Shilpa Waghmare | Whole-Time Director | 13-Jan-2005 | Current |
Financial Performance of Sulochana Nursing Home.
Sulochana Nursing Home Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.42% decrease. The company also saw a substantial improvement in profitability, with a 96.16% increase in profit. The company's net worth dipped by a decrease of 6.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sulochana Nursing Home?
In 2021, Sulochana Nursing Home had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Om Sai Super Speciality Hospitals Private LimitedActive 23 years 18 days
Anil Waghmare, Arjun Waghmare and 3 more are mutual person
- Intervention Clinic Private LimitedActive 17 years 6 months
Sunil Waghmare and Pratibha Waghmare are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sulochana Nursing Home?
Unlock and access historical data on people associated with Sulochana Nursing Home, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sulochana Nursing Home, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sulochana Nursing Home's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.